Meanwhile, augmented cell viability (Fig. 7D), migrating (Fig. 7E), and invasive (Fig. 7F) abilities were noted in CLIC1-overexpressed GC cells, which was reversed subsequent to further LY294002 treatment. The gene discussed is CLIC1; the disease is gastric cancer.